Methods This is a cross-sectional, descriptive study utilizing structured interviews to assess the level of education, usage, beliefs and attitudes towards BBT among inpatients with cardiovascular diseases. The study was conducted in the Cardiac Care Center at the Mount Sinai Hospital, New York, USA from February 2001 to December 2002. Participants provided informed consent and were interviewed by one of the investigators. To maintain consistency of the interview and to prevent interviewer bias, a scripted letter was drafted for the investigators to invite the patients to participate in the study and to explain the process of the study. After a patient was enrolled, an investigator read the survey questions verbatim to the patient and tried not to elaborate whenever possible. Patients were included in the study if they had at least one of the following diagnoses: cardiovascular disease(s) including congestive heart failure, coronary heart disease, thromboembolic diseases, valvular heart disease, arrhythmia, vascular aneurysm, peripheral vascular disease, pulmonary hypertension, congenital heart disease and post heart transplant. Additional inclusion criteria included being 18 years of age or older, English speaking, no documented cognitive deficits precluding the patient from understanding the interviewer, and willingness to provide an informed consent. Prior to patient contact, the attending physicians of the eligible patients were contacted and informed about the study. If the attending physicians chose not to have their patients participate in the study, the patients were not included. Upon agreement of the physicians, subjects were invited to participate and were asked to sign an informed consent at their convenience prior to being interviewed. This study was approved by the Institutional Review Boards of Mount Sinai Hospital and Long Island University. Biological based therapy survey Utilizing a structured instrument (see Additional file 1), eligible subjects were interviewed by one of the investigators during their stay at the hospital. The BBT survey was modified and adapted from a previously published survey [6]. The participants could choose to answer or not to answer any question at their discretion, and could discontinue their participation in the study at any time during the interview. During the interview, demographic data, including age, gender, race, marital status, level of education, annual income, and working status, were collected. Additionally, history of cardiovascular and other medical conditions, and medications utilized were recorded. The definition of BBT in this study was similar to that defined by the United States National Center for CAM, which included all herbal supplements, vitamins and mineral supplements. The patients' attitudes and beliefs towards BBT were assessed by asking them about their perceived safety and efficacy of BBT. The side effects and potential drug/food interactions listed by the patients were compared against those listed in the MicroMedex® Database [28]. The patients' assessments of benefits of BBT as compared with conventional medicine were recorded. Additionally, the participants were asked whether they reported the use of BBT to their physicians, pharmacists, or other healthcare professionals. A review of patients' medical records was performed to collect data about patients' cardiovascular diseases and to confirm medications used. Although, the identity of the participants in this research study was kept confidential, patients were notified in the informed consent process that if potential BBT-prescription medication interactions were identified, their physicians would be notified. Statistical analysis For this study to have an 80 percent power to detect a 20 percent clinically significant difference in determining factors of BBT use such as education level between the users and non-users of BBT, and establishing a p value of < 0.05 as the level of statistical significance, approximately 200 patients (100 patients in each group) needed to be enrolled. For demographic parameters, continuous variables were compared between the two groups using Students' t-test and categorical variables were compared using chi-square. Attitudes and beliefs regarding the safety and efficacy of BBT were compared between the two groups using a chi-square test for categorical data and Students' t test for Likert-type scale questions. The BBT products used by cardiovascular patients were recorded and the likelihood of potential drug interactions between BBT and other medications the patients were taking were described. Statistical analyses were conducted using Statistical Product and Service Solutions program (SPSS® for Windows, Rel. 10.01 1999).